8156 — Sinopharm Tech Holdings Share Price
Last trade - 00:00- HK$69.07m
- HK$215.03m
- HK$41.28m
- 18
- 30
- 70
- 31
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.67 | ||
| EV to EBITDA | 30.55 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | 6.96% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 165.93 | 77.81 | 40.98 | 42.84 | 41.28 | n/a | n/a | -1.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sinopharm Tech Holdings Limited is an investment holding company principally engaged in internet services. Along with subsidiaries, the Company operates its business through three segments. The Internet Plus Services segment is involved in the provision of supply chain services including operation of supply chain technology platform, provision of supply chain management, data analysis and trading of goods. The segment also provides internet plus solution services for lease, government affairs, public security and other industries. The Lottery Related Services segment is engaged in the provision of lottery transaction systems, lottery point of sale (POS) terminals and other lottery solutions. The Other Services segment is engaged in the provision of services including catering services and consultancy services.
Directors
- Ting Chan CHM (51)
- Kwai Lan Cheung NEC (82)
- Kam Kin Ho CFO
- Zhe Liao COO (34)
- Peng Zhao CTO (34)
- Ka Chun Cheuk EDR (37)
- Lau Fong Cheng OTH (53)
- King Him Fung OTH (42)
- Ping Ping Ho OTH (63)
- Wai Keung Ho OTH (39)
- Xi Chun Jia OTH (37)
- Shuk Yi Kwok OTH (36)
- Jie Lv OTH (35)
- Russell Young OTH (49)
- Yanjie Cheng NED (55)
- Wai Wah Chau NID (57)
- Fai Lau NID (48)
- Ta-pei Liu NID (66)
- Qing Cai Yang NID (66)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 11th, 2001
- Public Since
- November 12th, 2002
- No. of Employees
- 30
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 633,693,000
- Address
- Units 307-313, 3/F., Wireless Centre,
- Web
- https://www.sinopharmtech.com.hk/
- Phone
- +852 null24115779
- Auditors
- SFAI (HK) CPA Limited
Upcoming Events for 8156
Similar to 8156
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:16 UTC, shares in Sinopharm Tech Holdings are trading at HK$0.11. This share price information is delayed by 15 minutes.
Shares in Sinopharm Tech Holdings last closed at HK$0.11 and the price had moved by +17.2% over the past 365 days. In terms of relative price strength the Sinopharm Tech Holdings share price has outperformed the FTSE Developed Asia Pacific Index by +18.54% over the past year.
There is no consensus recommendation for this security.
Find out moreSinopharm Tech Holdings does not currently pay a dividend.
Sinopharm Tech Holdings does not currently pay a dividend.
Sinopharm Tech Holdings does not currently pay a dividend.
To buy shares in Sinopharm Tech Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.11, shares in Sinopharm Tech Holdings had a market capitalisation of HK$69.07m.
Here are the trading details for Sinopharm Tech Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 8156
Based on an overall assessment of its quality, value and momentum Sinopharm Tech Holdings is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sinopharm Tech Holdings. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +17.86%.
As of the last closing price of HK$0.11, shares in Sinopharm Tech Holdings were trading +4.53% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sinopharm Tech Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.11.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Sinopharm Tech Holdings' management team is headed by:
- Ting Chan - CHM
- Kwai Lan Cheung - NEC
- Kam Kin Ho - CFO
- Zhe Liao - COO
- Peng Zhao - CTO
- Ka Chun Cheuk - EDR
- Lau Fong Cheng - OTH
- King Him Fung - OTH
- Ping Ping Ho - OTH
- Wai Keung Ho - OTH
- Xi Chun Jia - OTH
- Shuk Yi Kwok - OTH
- Jie Lv - OTH
- Russell Young - OTH
- Yanjie Cheng - NED
- Wai Wah Chau - NID
- Fai Lau - NID
- Ta-pei Liu - NID
- Qing Cai Yang - NID